The genetics of human autoimmune disease: A perspective on progress in the field and future directions

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Progress in defining the genetics of autoimmune disease has been dramatically enhanced by large scale genetic studies. Genome-wide approaches, examining hundreds or for some diseases thousands of cases and controls, have been implemented using high throughput genotyping and appropriate algorithms to provide a wealth of data over the last decade. These studies have identified hundreds of non-HLA loci as well as further defining HLA variations that predispose to different autoimmune diseases. These studies to identify genetic risk loci are also complemented by progress in gene expression studies including definition of expression quantitative trait loci (eQTL), various alterations in chromatin structure including histone marks, DNase I sensitivity, repressed chromatin regions as well as transcript factor binding sites. Integration of this information can partially explain why particular variations can alter proclivity to autoimmune phenotypes. Despite our incomplete knowledge base with only partial definition of hereditary factors and possible functional connections, this progress has and will continue to facilitate a better understanding of critical pathways and critical changes in immunoregulation. Advances in defining and understanding functional variants potentially can lead to both novel therapeutics and personalized medicine in which therapeutic approaches are chosen based on particular molecular phenotypes and genomic alterations.

Original languageEnglish (US)
Article number1811
Pages (from-to)1-12
Number of pages12
JournalJournal of Autoimmunity
Volume64
DOIs
StatePublished - Nov 1 2015

Fingerprint

Medical Genetics
Autoimmune Diseases
Chromatin
Histone Code
Phenotype
Precision Medicine
Inborn Genetic Diseases
Critical Pathways
Genetic Loci
Knowledge Bases
Quantitative Trait Loci
Deoxyribonuclease I
Binding Sites
Genome
Gene Expression
Therapeutics
Direction compound

Keywords

  • Autoimmune diseases
  • Functional variants
  • Genetics
  • HLA
  • Immunoregulation
  • Susceptibility loci

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

The genetics of human autoimmune disease : A perspective on progress in the field and future directions. / Seldin, Michael F.

In: Journal of Autoimmunity, Vol. 64, 1811, 01.11.2015, p. 1-12.

Research output: Contribution to journalArticle

@article{edd4ce6590e44eba8d44cf3c9e86daa3,
title = "The genetics of human autoimmune disease: A perspective on progress in the field and future directions",
abstract = "Progress in defining the genetics of autoimmune disease has been dramatically enhanced by large scale genetic studies. Genome-wide approaches, examining hundreds or for some diseases thousands of cases and controls, have been implemented using high throughput genotyping and appropriate algorithms to provide a wealth of data over the last decade. These studies have identified hundreds of non-HLA loci as well as further defining HLA variations that predispose to different autoimmune diseases. These studies to identify genetic risk loci are also complemented by progress in gene expression studies including definition of expression quantitative trait loci (eQTL), various alterations in chromatin structure including histone marks, DNase I sensitivity, repressed chromatin regions as well as transcript factor binding sites. Integration of this information can partially explain why particular variations can alter proclivity to autoimmune phenotypes. Despite our incomplete knowledge base with only partial definition of hereditary factors and possible functional connections, this progress has and will continue to facilitate a better understanding of critical pathways and critical changes in immunoregulation. Advances in defining and understanding functional variants potentially can lead to both novel therapeutics and personalized medicine in which therapeutic approaches are chosen based on particular molecular phenotypes and genomic alterations.",
keywords = "Autoimmune diseases, Functional variants, Genetics, HLA, Immunoregulation, Susceptibility loci",
author = "Seldin, {Michael F}",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.jaut.2015.08.015",
language = "English (US)",
volume = "64",
pages = "1--12",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - The genetics of human autoimmune disease

T2 - A perspective on progress in the field and future directions

AU - Seldin, Michael F

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Progress in defining the genetics of autoimmune disease has been dramatically enhanced by large scale genetic studies. Genome-wide approaches, examining hundreds or for some diseases thousands of cases and controls, have been implemented using high throughput genotyping and appropriate algorithms to provide a wealth of data over the last decade. These studies have identified hundreds of non-HLA loci as well as further defining HLA variations that predispose to different autoimmune diseases. These studies to identify genetic risk loci are also complemented by progress in gene expression studies including definition of expression quantitative trait loci (eQTL), various alterations in chromatin structure including histone marks, DNase I sensitivity, repressed chromatin regions as well as transcript factor binding sites. Integration of this information can partially explain why particular variations can alter proclivity to autoimmune phenotypes. Despite our incomplete knowledge base with only partial definition of hereditary factors and possible functional connections, this progress has and will continue to facilitate a better understanding of critical pathways and critical changes in immunoregulation. Advances in defining and understanding functional variants potentially can lead to both novel therapeutics and personalized medicine in which therapeutic approaches are chosen based on particular molecular phenotypes and genomic alterations.

AB - Progress in defining the genetics of autoimmune disease has been dramatically enhanced by large scale genetic studies. Genome-wide approaches, examining hundreds or for some diseases thousands of cases and controls, have been implemented using high throughput genotyping and appropriate algorithms to provide a wealth of data over the last decade. These studies have identified hundreds of non-HLA loci as well as further defining HLA variations that predispose to different autoimmune diseases. These studies to identify genetic risk loci are also complemented by progress in gene expression studies including definition of expression quantitative trait loci (eQTL), various alterations in chromatin structure including histone marks, DNase I sensitivity, repressed chromatin regions as well as transcript factor binding sites. Integration of this information can partially explain why particular variations can alter proclivity to autoimmune phenotypes. Despite our incomplete knowledge base with only partial definition of hereditary factors and possible functional connections, this progress has and will continue to facilitate a better understanding of critical pathways and critical changes in immunoregulation. Advances in defining and understanding functional variants potentially can lead to both novel therapeutics and personalized medicine in which therapeutic approaches are chosen based on particular molecular phenotypes and genomic alterations.

KW - Autoimmune diseases

KW - Functional variants

KW - Genetics

KW - HLA

KW - Immunoregulation

KW - Susceptibility loci

UR - http://www.scopus.com/inward/record.url?scp=84946483562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946483562&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2015.08.015

DO - 10.1016/j.jaut.2015.08.015

M3 - Article

C2 - 26343334

AN - SCOPUS:84946483562

VL - 64

SP - 1

EP - 12

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

M1 - 1811

ER -